THL Credit, Inc. (TCRD) COO & CFO Terrence Olson, Acquires $449996 in Stock; Redwood Investments Has Boosted Horizon Pharma Plc (HZNP) Stake By $5.64 Million

Horizon Pharma Public Limited Company (NASDAQ:HZNP) Logo

Redwood Investments Llc increased Horizon Pharma Plc (HZNP) stake by 43.88% reported in 2018Q1 SEC filing. Redwood Investments Llc acquired 402,610 shares as Horizon Pharma Plc (HZNP)’s stock rose 10.83%. The Redwood Investments Llc holds 1.32 million shares with $18.75 million value, up from 917,471 last quarter. Horizon Pharma Plc now has $2.73B valuation. The stock increased 0.98% or $0.16 during the last trading session, reaching $16.56. About 1.44 million shares traded. Horizon Pharma Public Limited Company (NASDAQ:HZNP) has risen 62.19% since July 1, 2017 and is uptrending. It has outperformed by 49.62% the S&P500. Some Historical HZNP News: 09/05/2018 – HORIZON PHARMA BOOSTS YEAR 2018 GUIDANCE; 08/05/2018 – Horizon Pharma Announces the U.S. Patent and Trademark Office Issued Additional Notices of Allowance With Claims Covering Ravicti Oral Liquid; 09/05/2018 – Horizon Pharma 1Q EBITDA $33.6M; 03/05/2018 – Horizon Pharma plc Announces Sangita Iyer as a 2018 Healthcare Businesswomen’s Association Rising Star; 08/05/2018 – HORIZON PHARMA PLC – ANNOUNCES U.S. PATENT AND TRADEMARK OFFICE ISSUANCE OF ADDITIONAL NOTICES OF ALLOWANCE WITH CLAIMS COVERING RAVICTI ORAL LIQUID; 03/05/2018 – AGC BIOLOGICS SAYS ENTERS INTO COMMERCIAL MANUFACTURING AGREEMENT WITH HORIZON PHARMA PLC FOR COMMERCIAL SUPPLY OF TEPROTUMUMAB; 14/05/2018 – Horizon Pharma Closes Above 50-Day Moving Average: Technicals; 08/05/2018 – HORIZON PHARMA GETS 2 NOTICES OF ALLOWANCE ON RAVICTI PATENTS; 09/05/2018 – Horizon Pharma 1Q Loss/Shr 96c; 09/05/2018 – HORIZON PHARMA PLC – SEES 2018 ADJ EBITDA GUIDANCE RANGE TO $390 MLN TO $415 MLN

At an average price-per-share of $7.9, Terrence Olson, the Thl Credit Inc’s COO & CFO paid for 56,703 shares of Thl Credit Inc worth close to $449,996 U.S Dollars . In the last month, he also purchased 657,227 shares with a market value $5.20 million USD. This investment was pretty huge one, so clearly it won’t go ignored. At the moment, Terrence Olson has in hand a total of 1.12 million shares or 3.44% of the company’s market capitalization.

Investors sentiment increased to 1.27 in 2018 Q1. Its up 0.30, from 0.97 in 2017Q4. It improved, as 8 investors sold THL Credit, Inc. shares while 18 reduced holdings. 11 funds opened positions while 22 raised stakes. 12.21 million shares or 1.93% more from 11.98 million shares in 2017Q4 were reported. Athena Ltd Llc owns 298,285 shares for 0.58% of their portfolio. Bb&T Limited Company owns 131,288 shares. 88,662 are held by Raymond James Fincl Serv Inc. Pnc Finance Serv Gru invested 0% in THL Credit, Inc. (NASDAQ:TCRD). Asset Management has invested 0.09% in THL Credit, Inc. (NASDAQ:TCRD). Shikiar Asset Mgmt has 184,475 shares for 0.65% of their portfolio. Cibc reported 10,476 shares stake. Ares Mgmt Ltd Com accumulated 798,961 shares. Tower Rech Cap Llc (Trc) reported 0.01% in THL Credit, Inc. (NASDAQ:TCRD). New Jersey-based Private Advisor Group Incorporated has invested 0.02% in THL Credit, Inc. (NASDAQ:TCRD). Kempner Cap Mngmt owns 11,900 shares for 0.06% of their portfolio. Lsv Asset Mngmt holds 0.01% or 758,293 shares. Macquarie Gru Limited holds 26,031 shares or 0% of its portfolio. Great West Life Assurance Communications Can holds 0.03% of its portfolio in THL Credit, Inc. (NASDAQ:TCRD) for 1.43M shares. Janney Montgomery Scott Ltd Co accumulated 18,490 shares or 0% of the stock.

Among 4 analysts covering THL Credit (NASDAQ:TCRD), 0 have Buy rating, 0 Sell and 4 Hold. Therefore 0 are positive. THL Credit has $9.5 highest and $9.0 lowest target. $9.17’s average target is 17.26% above currents $7.82 stock price. THL Credit had 4 analyst reports since March 8, 2018 according to SRatingsIntel. The firm has “Hold” rating given on Thursday, March 8 by Deutsche Bank. The firm has “Hold” rating given on Wednesday, March 7 by Keefe Bruyette & Woods. The stock of THL Credit, Inc. (NASDAQ:TCRD) has “Hold” rating given on Wednesday, March 7 by Jefferies. The rating was downgraded by Maxim Group to “Hold” on Thursday, March 8.

Analysts await THL Credit, Inc. (NASDAQ:TCRD) to report earnings on August, 2. They expect $0.27 earnings per share, down 12.90% or $0.04 from last year’s $0.31 per share. TCRD’s profit will be $8.82M for 7.24 P/E if the $0.27 EPS becomes a reality. After $0.27 actual earnings per share reported by THL Credit, Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Since March 9, 2018, it had 14 insider purchases, and 3 sales for $4.30 million activity. On Monday, March 12 the insider Flynn Christopher J. bought $12,336. Olson Terrence W. bought 370,340 shares worth $2.90M. $124,344 worth of THL Credit, Inc. (NASDAQ:TCRD) was bought by Fellows James R on Monday, March 12. Tillinghast Sam W. sold 50,000 shares worth $410,905. Rusnak-Carlson Sabrina bought 1 shares worth $8.

The stock decreased 0.51% or $0.04 during the last trading session, reaching $7.82. About 164,645 shares traded or 32.80% up from the average. THL Credit, Inc. (NASDAQ:TCRD) has declined 20.63% since July 1, 2017 and is downtrending. It has underperformed by 33.20% the S&P500. Some Historical TCRD News: 22/05/2018 – THL Credit Senior Loan Fund: Plans to Reschedule Meeting in 2018; 02/05/2018 – THL CREDIT 1Q INVESTMENT EPS 27C, EST. 29C; 22/05/2018 – THL CREDIT SR LOAN FUND TO RESCHEDULE MEETING LATER THIS YEAR; 02/04/2018 – Credit Industry Veteran Jane Musser Nelson Joins THL Credit’s Board of Directors; 24/05/2018 – THL Credit Senior Loan Fund Announces Board Approval of THL Credit Advisors LLC to Serve as Sole Investment Adviser along with Reduction in Advisory Fee; 06/03/2018 – THL Credit: Net Investment Income $1.21/Share at Dec. 31; 07/03/2018 – THL Credit Senior Loan Fund Declares Monthly Distribution of $0.096 Per Share and Announces Investor Call; 27/04/2018 – Factors of Influence in 2018, Key Indicators and Opportunity within Guidewire Software, THL Credit, Oil States International, B; 02/04/2018 – Credit Industry Veteran Jane Musser Nelson Joins THL Credit’s Board of Directors; 24/05/2018 – THL Credit Senior Loan Fund: Current Advisory Agreement With Four Wood Capital Will Terminate June 21

More notable recent Horizon Pharma Public Limited Company (NASDAQ:HZNP) news were published by: Nasdaq.com which released: “Horizon Pharma plc Presents Data at EULAR 2018 Advancing the Understanding and Management of Uncontrolled Gout” on June 15, 2018, also Nasdaq.com with their article: “Report: Exploring Fundamental Drivers Behind Horizon Pharma Public, Lululemon Athletica, Nordic American Tankers …” published on June 07, 2018, Nasdaq.com published: “Horizon Pharma plc and the National Organization for Rare Disorders (NORD) Illustrate 35 years of Progress in Rare …” on June 04, 2018. More interesting news about Horizon Pharma Public Limited Company (NASDAQ:HZNP) were released by: Businesswire.com and their article: “NIRI-Chicago Elects 2018-2019 Officers and Directors” published on June 27, 2018 as well as Streetinsider.com‘s news article titled: “Horizon Pharma plc (HZNP) Highlights Multiple Analyses of KRYSTEXXA (pegloticase injection) Clinical Trial Data at …” with publication date: June 15, 2018.

Among 8 analysts covering Horizon Pharma (NASDAQ:HZNP), 6 have Buy rating, 0 Sell and 2 Hold. Therefore 75% are positive. Horizon Pharma has $24.0 highest and $16 lowest target. $19.86’s average target is 19.93% above currents $16.56 stock price. Horizon Pharma had 12 analyst reports since January 12, 2018 according to SRatingsIntel. Cantor Fitzgerald maintained it with “Buy” rating and $1700 target in Sunday, April 15 report. The rating was maintained by Piper Jaffray on Wednesday, February 28 with “Buy”. The stock of Horizon Pharma Public Limited Company (NASDAQ:HZNP) earned “Buy” rating by Cowen & Co on Wednesday, February 28. The rating was maintained by Piper Jaffray on Tuesday, January 30 with “Buy”. The firm has “Neutral” rating given on Wednesday, June 27 by Citigroup. The stock of Horizon Pharma Public Limited Company (NASDAQ:HZNP) earned “Buy” rating by UBS on Thursday, March 1. The firm has “Equal-Weight” rating given on Friday, March 2 by Morgan Stanley. Stifel Nicolaus maintained Horizon Pharma Public Limited Company (NASDAQ:HZNP) rating on Monday, June 18. Stifel Nicolaus has “Buy” rating and $22 target. The stock of Horizon Pharma Public Limited Company (NASDAQ:HZNP) has “Buy” rating given on Wednesday, April 11 by Mizuho. Mizuho maintained Horizon Pharma Public Limited Company (NASDAQ:HZNP) rating on Monday, May 7. Mizuho has “Buy” rating and $1800 target.

Investors sentiment increased to 1.38 in 2018 Q1. Its up 0.34, from 1.04 in 2017Q4. It is positive, as 12 investors sold HZNP shares while 53 reduced holdings. 36 funds opened positions while 54 raised stakes. 127.87 million shares or 0.61% less from 128.65 million shares in 2017Q4 were reported. Portfolio Solutions Limited Liability Com reported 0% in Horizon Pharma Public Limited Company (NASDAQ:HZNP). Wellington Gp Limited Liability Partnership holds 101,346 shares. Royal Bancshares Of Canada stated it has 0% in Horizon Pharma Public Limited Company (NASDAQ:HZNP). 99,787 were reported by Susquehanna Gru Llp. Texas-based Teacher Retirement Systems Of Texas has invested 0% in Horizon Pharma Public Limited Company (NASDAQ:HZNP). Walleye Trading Ltd Liability Com has 0% invested in Horizon Pharma Public Limited Company (NASDAQ:HZNP) for 914 shares. Jpmorgan Chase And holds 3.52M shares. Alyeska Grp Lp reported 0.06% stake. Rothschild Asset Mngmt Inc holds 1.70 million shares. Glenmede Com Na holds 0.22% or 3.64 million shares in its portfolio. 181,405 are owned by Rhumbline Advisers. Voya Management Limited Com reported 72,479 shares or 0% of all its holdings. One Trading Lp has 0.01% invested in Horizon Pharma Public Limited Company (NASDAQ:HZNP) for 91,869 shares. Pnc Ser Group stated it has 1,213 shares. Services Automobile Association owns 24,357 shares.

Since May 25, 2018, it had 0 insider buys, and 3 selling transactions for $1.91 million activity. Walbert Timothy P also sold $1.35M worth of Horizon Pharma Public Limited Company (NASDAQ:HZNP) shares. 17,931 Horizon Pharma Public Limited Company (NASDAQ:HZNP) shares with value of $288,868 were sold by Beeler Brian K.

THL Credit, Inc. (NASDAQ:TCRD) Institutional Positions Chart